Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

leucinostatin A

Known as: paecilotoxin A 
 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

Peptidesleucinostatin

Narrower (1)

leucinostatin A, hydrochloride

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Chemical Studies on Bioactive Natural Products Directed toward Development of Novel Antiinfective and Anticancer Medicines.
Natural products are still rich sources of clinically used medicines and lead compounds for them. This review summarizes chemical… Expand
2010
2010
Leucinostatin A inhibits prostate cancer growth through reduction of insulin‐like growth factor‐I expression in prostate stromal cells
Targeting stroma in tumor tissues is an attractive new strategy for cancer treatment. We developed in vitro coculture system, in… Expand
2009
2009
In vitro and in vivo antitrypanosomal activities of three peptide antibiotics: leucinostatin A and B, alamethicin I and tsushimycin
In the course of our screening for antitrypanosomal compounds from soil microorganisms, as well as from the antibiotics library… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
2009
2009
In vitro and in vivo antitrypanosomal activities of three peptide antibiotics: leucinostatin A and B, alamethicin I and tsushimycin
In the course of our screening for antitrypanosomal compounds from soil microorganisms, as well as from the antibiotics library… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
1997
1997
Glucosylation of the peptide leucinostatin A, produced by an endophytic fungus of European yew, may protect the host from leucinostatin toxicity.
BACKGROUND Yew species (Taxus spp.) throughout the world are hosts to hundreds, or perhaps thousands, of endophytic organisms… Expand
1996
1996
Novel blockade of cell surface expression of virus glycoproteins by leucinostatin A.
The nonapeptide leucinostatin A (LSA) inhibited syncytium formation without profoundly affecting HN glycoprotein synthesis in… Expand
1995
1995
Structure activity studies on chemically modified homologues of the antibiotic phytotoxic leucinostatin A.
The synthesis and a conformational study of a number of homologues of the well known antibiotic, phytotoxic leucinostatin A are… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
1994
1994
The nonapeptide leucinostatin A acts as a weak ionophore and as an immunosuppressant on T lymphocytes.
Earlier studies have disclosed that leucinostatin A, a hydrophobic nonapeptide antibiotic, assumes an alpha-helical secondary… Expand
  • figure 1
  • figure 3
  • figure 2
  • figure 4
  • figure 6
1989
1989
The crystal and molecular structure of the alpha-helical nonapeptide antibiotic leucinostatin A.
The crystal and molecular structure of the nonapeptide antibiotic leucinostatin A, containing some uncommon amino acids and three… Expand
1982
1982
Isolation of leucinostatin A and one of its constituents, the new amino acid, 4-methyl-6-(2-oxobutyl)-2-piperidinecarboxylic acid, from Paecilomyces lilacinus A-267.
Sir: A new antibiotic, leucinostatin, was isolated from the culture filtrate of Paecilomyces lilacinus A-267. The peptide… Expand
  • figure 1
  • table 1
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE